A carregar...

Drug-Drug Interaction Study of Ketoconazole and Ritonavir-Boosted Saquinavir

Saquinavir, a potent human immunodeficiency virus protease inhibitor, is extensively metabolized by CYP3A4. Saquinavir is coadministered with ritonavir, a strong CYP3A4 inhibitor, to boost its exposure. Ketoconazole is a potent CYP3A inhibitor. The objectives of this study were to investigate the ef...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Kaeser, Benoite, Zandt, Hagen, Bour, Fabrice, Zwanziger, Elke, Schmitt, Christophe, Zhang, Xiaoping
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology (ASM) 2009
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2630604/
https://ncbi.nlm.nih.gov/pubmed/19015329
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00769-08
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!